U.S. Other Utilities Stock News

Earlier this month, Ondas Holdings Inc. reported that third-quarter 2025 sales surged to US$10.1 million from US$1.48 million a year earlier, with narrowed net losses and improved loss per share figures. The sales growth was fueled by increased deliveries of its drone and wireless systems, contributions from recent acquisitions, and heightened demand in the autonomous systems market. We'll explore how the substantial year-over-year revenue growth influences Ondas Holdings' investment...

Uranium Energy Corp. recently launched a US$600 million at-the-market equity sales program with Goldman Sachs as lead manager, alongside filing a universal shelf registration for various securities and raising about US$204 million last month to support a new American uranium facility. This wave of capital-raising comes as uranium was newly added to the U.S. Critical Minerals List, highlighting its importance for national security and domestic energy production. We’ll explore what Uranium...

Earlier this month, Recursion Pharmaceuticals reported a sharp year-over-year decline in third-quarter revenue to US$5.18 million alongside a very large net loss, while also announcing that Dr. Najat Khan will become Chief Executive Officer and President effective January 1, 2026, with Dr. Christopher Gibson transitioning to Chair of the Board. These leadership transitions bring an executive with deep data science and pharmaceutical experience to the forefront at a time when operational and...

Merus (MRUS) has caught the interest of investors following recent developments around its financial results and product pipeline. Shares have delivered a strong return of over 120% in the past year, pointing to distinct momentum in the stock. See our latest analysis for Merus. Merus has maintained strong momentum, as shown by a 126% year-to-date share price return and a remarkable 120% one-year total shareholder return. Recent upticks reflect bullish sentiment following advancements in its...

XP Inc. (NasdaqGS:XP) just released its third quarter results, showing year-over-year growth in both revenue and net income. The earnings came alongside news of a fresh share buyback and a new cash dividend. See our latest analysis for XP. XP’s share price has climbed 56% so far this year and currently sits at $18.45. This reflects renewed optimism after steady gains in revenue and a series of capital returns. Notably, its 1-year total shareholder return of nearly 24% signals meaningful...

D.R. Horton (DHI) shares have edged up in recent trading, rising just under 1% over the past day. Investors seem to be weighing company fundamentals and broader housing sector trends as they consider the stock's next move. See our latest analysis for D.R. Horton. D.R. Horton’s share price has cooled alongside housing sector sentiment, sliding over the last month and down nearly 10% in the past 30 days. Momentum has tapered compared to the stellar multi-year run that saw a 73% total return...

Advanced Drainage Systems recently reported strong second-quarter results, with sales rising to US$850.38 million and net income reaching US$156.02 million, alongside announcing a 13% increase in its quarterly dividend to US$0.18 per share payable on December 15, 2025. The company has completed the repurchase of 8,244,000 shares for US$852.26 million under its ongoing buyback program, indicating a substantial commitment to returning capital to investors. With the company's dividend boost...

Insmed Incorporated recently announced that the European Commission has approved BRINSUPRI (brensocatib 25 mg tablets) for treating non-cystic fibrosis bronchiectasis (NCFB) in patients aged 12 and up with two or more exacerbations in the previous year, offering the first and only approved therapy for this condition in the European Union. This approval marks a significant milestone for Insmed, as BRINSUPRI was reviewed under accelerated assessment and supported by data from robust Phase 3...

Ever wondered if Steven Madden's current share price offers real value, or if it's hiding a bargain in plain sight? This is the question that both experienced and first-time investors are asking right now. After a recent 6.3% rebound over 30 days, Steven Madden's stock has still slipped 11.4% year-to-date and is down 8.2% over the last year, so there's plenty of debate around whether the risks or opportunities are winning out. Market watchers are buzzing about shifting consumer trends and...

Kulicke and Soffa Industries (KLIC) stock has seen some movement lately as investors look for signs of momentum in the semiconductor space. The shares are coming off a rough stretch, which invites a closer look at valuation. See our latest analysis for Kulicke and Soffa Industries. This year’s story for Kulicke and Soffa Industries is one of fading momentum, after a sharp 1-week share price decline of 8.8% and a year-to-date slide of 24.4%. Over the longer term, the total shareholder return...

Kuehn Law, PLLC recently launched an investigation into whether officers and directors of iRhythm Technologies breached fiduciary duties by allegedly misrepresenting the intended use of the Zio AT monitor for high-risk patients. This development raises concerns about corporate governance and transparency, as the investigation centers on the accuracy of disclosures and potential impacts on shareholder trust. We'll explore how heightened legal scrutiny around the Zio AT monitor's disclosures...

Coinbase Global and stablecoin infrastructure startup BVNK have called off their planned US$2 billion acquisition, according to Fortune, after it entered the due diligence stage in October; the deal’s termination reason was not immediately disclosed and came as Coinbase launched an interest-bearing savings account in the UK offering 3.75% annual interest, powered by ClearBank and covered by the country’s deposit protection scheme. The simultaneous cancellation of a major acquisition and the...

Nutanix (NTNX) stock has been in the spotlight as investors consider its recent performance and growth prospects. Shares have given up some gains over the past month, which has prompted a closer look at what the numbers say about valuation and momentum. See our latest analysis for Nutanix. After climbing earlier in the year, Nutanix shares have cooled off recently, with a 30-day share price return of -6.21% and a year-to-date gain of 4.46%. Despite this short-term dip, the stock's...

Western Digital (WDC) stock has seen impressive gains over the past month, climbing 26%. Investors are showing more interest as the company's recent results point to steady annual growth in both revenue and net income. See our latest analysis for Western Digital. After a breathless 104.7% share price rally in the last three months, Western Digital is clearly picking up steam with investors. The strong 1-year total shareholder return of 217.8% highlights momentum. Recent gains point to renewed...

From July to September 2025, Wintrust Financial reported no share repurchases, concluding its buyback program announced in 2019 with the full repurchase of 1,684,681 shares for US$101.41 million, while a separate 2021 buyback program remained inactive. An interesting development is Wintrust’s successful May 2025 refinancing, raising US$415 million to redeem preferred securities and reinforcing its focus on organic growth and financial stability. We’ll explore how Wintrust’s organic growth...

Exxon Mobil is teaming up with BASF in a strategic partnership to develop methane pyrolysis technology for producing low-emission hydrogen and solid carbon. This initiative draws on existing natural gas infrastructure and could open new opportunities in the industrial hydrogen market. See our latest analysis for Exxon Mobil. Exxon Mobil’s newly announced partnership with BASF has drawn investor attention, with the 30-day share price return climbing 6.05 percent. Momentum has been picking up...

Kinder Morgan (KMI) has delivered steady results lately, with the stock showing both gains and pullbacks over the past few months. Investors may be watching closely for signals from recent company performance as well as sector dynamics to inform their next move. See our latest analysis for Kinder Morgan. Kinder Morgan’s share price has drifted slightly this year, down roughly 3.6% year-to-date, but the company’s longer-term track record stands out, with a remarkable 71% total return over the...

Wondering if Rezolve AI is a hidden bargain or an overhyped play? You are not alone; investors have been watching the price action closely. The stock jumped 12.6% over the past year, but has retreated sharply in the last month with a -40.6% drop, pointing to shifting investor sentiment and fresh risk perceptions. Recent headlines have focused on Rezolve AI's strategic partnerships and moves to expand its AI-driven platform, fueling optimism earlier this year. However, some investors are now...

Alamo Group (ALG) just shared its third quarter results, and the numbers are stirring up discussion. Sales climbed compared to last year, but net income slipped as challenges affected the Vegetation Management division. See our latest analysis for Alamo Group. Alamo Group’s share price tells a story of mixed momentum. After a rally earlier this year, the stock has lost steam, with a 30-day share price return of -9.9% and a steeper 90-day slide of -24%. This reflects investor concerns over...

Earlier this month, Exact Sciences announced pivotal results from its ALTUS study showing its Oncoguard Liver blood test achieved far higher early-stage and overall detection rates for hepatocellular carcinoma compared to ultrasound, with the findings presented as late-breaking data at the AASLD's Liver Meeting on November 11, 2025. This outcome, from the largest real-world prospective trial of its kind in the US, highlights the Oncoguard Liver test's potential to change liver cancer...

In recent days, financial commentator Jim Cramer voiced concerns about Conagra Brands' flat revenue growth and the sustainability of its high 7.6% dividend yield, cautioning that a possible dividend cut could negatively impact the company’s stock. While Conagra Brands announced employee-led sustainability achievements and community investment grants, investor attention remained fixed on financial headwinds and risks to ongoing dividends. Next, we'll look at how these renewed concerns over...

Wondering if ICON stock might be undervalued, or if it is a hidden opportunity waiting to be discovered? You are not alone, as many investors are keen to know whether now is the right time to take a closer look at ICON. The share price has seen some turbulence lately, dropping 1.1% over the past week and down 24.0% year-to-date. These moves catch the eye of anyone tracking long-term value or short-term momentum. Recent industry headlines have highlighted ongoing changes in the clinical...

Ever wondered whether Berkshire Hathaway is actually a good deal at today's lofty price, or if you're just chasing the name? Let's cut through the noise and talk real value. The stock has climbed 1.3% in the past week, 2.4% over the last 30 days, and boasts a steady 11.9% year-to-date return. This shows both momentum and resilience that catch investors' attention. Recently, headlines have zeroed in on Warren Buffett's ongoing strategy shifts and new investment disclosures, raising fresh...

Ever wondered whether McDonald's is serving up good value for investors as well as customers? Let’s dig in and see if the current share price offers a tasty opportunity or if the stock is overcooked. After hitting $304.59, McDonald's stock is up 4.1% year-to-date and has delivered a solid 7.2% return over the last 12 months. However, it has dipped 0.7% in the past week and 1.1% in the last month. Recently, headlines have highlighted McDonald's push into digital ordering and expansion of its...